Ulcerative Colitis - before and after Hurst

Slides:



Advertisements
Similar presentations
Opportunistic Bacterial Infections in Inflammatory Bowel Disease By: Christina Philips.
Advertisements

The Microbiome: What’s the immune system got to do with it?
TL1A Expression in Human IBD and Animal Models
JAIMEE DOUCETTE T HELPER CELLS IN IBD. OVERVIEW Background Information on T Helper cells What is known about Th cells in IBD? What is still unknown about.
An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation Barrette Kathleen – Dreesen Erwin Asseman.
Microbes and Allergic Disease Cathryn Nagler-Anderson Massachusetts General Hospital Harvard Medical School.
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.
Evaluation of the genetic impact on inflammatory bowel disease Natalie Bibb Trainee Project KGC.
KEY CONCEPT Genetics provides a basis for new medical treatments.
KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.
Immunology --- prevention and treatment of infectious diseases
Specific Host Defenses: The Immune Response. The Immune Response Immunity: “Free from burden”. Ability of an organism to recognize and defend itself against.
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Toll-Like Receptors in CNS Viral Infections Unclear role of TLRs in natural infections TLR3, -7, -8, -9 recognize viral nucleic acids. Localized intracellularly.
Crohn Disease : from gene to therapy
Innate immunity Properties of innate immunity Recognition of microbes by innate immune system –structures that are recognized (“molecular patterns”) –receptors.
The Human Microbiome: PSC, IBD, and the Gut-Liver Axis
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
Autoimmunity and Type I Diabetes CCMD 793A: Fundamental Integrated SystemsFALL, 2006 James M. Sheil, Ph.D.
The Inflammasome: Critical Roles in Intestinal Homeostasis Hasan Zaki, PhD Department of Pathology UT Southwestern Medical Center.
Enteric defensins are essential regulators of intestinal micorbial ecology Nita Salzman Nature immunolgy 11,
Basic Concepts of Immunology Scott Barnum, Ph.D..
WORLD DIGESTIVE HEALTH DAY
Chapter 3 Innate Immunity Dr. Capers. Kuby IMMUNOLOGY Sixth Edition Chapter 3 Innate Immunity Copyright © 2007 by W. H. Freeman and Company Kindt Goldsby.
CATEGORY: IMMUNE DEVELOPMENT Neonatal Immunology John Tregoning, St George’s University of London, UK Introduction Like many other systems in the body,
9.1 Manipulating DNA KEY CONCEPT Biotechnology relies on cutting DNA at specific places.
Effector T Cell Subsets, Cytokines
Shotgun sequencing reveals transkingdom alterations in immunodeficiency associated enteropathy Xiaoxi Dong (Oregon State University), Jialu Hu (Oregon.
Environmental factors Dysregulated immune response
INTERNATIONAL SYMPOSIUM ON FUNDED BY PATIENTS' ORGANISATIONS
CATEGORY: IMMUNE DEVELOPMENT
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Ulcerative colitis andTrichuris infection
Ch 15: The Immune System.
Inflamm Intest Dis 2016;1: DOI: /
Autoimmune diseases Ch. 4 p (99 – 159) March 7 /2016 March
Avoiding Immune Detection
Volume 31, Issue 3, Pages (September 2009)
KEY CONCEPT Genetics provides a basis for new medical treatments.
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Microbial Influences in Inflammatory Bowel Diseases
Gut Microbiota: Mining for Therapeutic Potential
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Figure 1 Environmental factors contributing to IBD pathogenesis
KEY CONCEPT Genetics provides a basis for new medical treatments.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Warren Strober, Ivan J. Fuss  Gastroenterology 
The Intestinal Immune System in Obesity and Insulin Resistance
Kei E. Fujimura, Susan V. Lynch  Cell Host & Microbe 
Advances and Perspectives in the Genetics of Inflammatory Bowel Diseases  Mathias Chamaillard, Razvan Iacob, Pierre Desreumaux, Jean–Frederic Colombel 
In Vivo Role of pDCs in Regulating Adaptive Immunity
Maya Saleh, Charles O. Elson  Immunity 
Volume 146, Issue 4, Pages e1 (April 2014)
Old Meets New: The Interaction Between Innate and Adaptive Immunity
Translating Inflammatory Bowel Disease Research into Clinical Medicine
KEY CONCEPT Genetics provides a basis for new medical treatments.
Homeostasis and Inflammation in the Intestine
Daniel A. Peterson, Daniel N. Frank, Norman R. Pace, Jeffrey I. Gordon 
KEY CONCEPT Genetics provides a basis for new medical treatments.
Route Connection: Mouth to Intestine in Colitis
Learning Tolerance while Fighting Ignorance
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Volume 31, Issue 3, Pages (September 2009)
General overview of innate and adaptive immune responses to and regulation of black yeasts. General overview of innate and adaptive immune responses to.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Inflammation caused by microbes.
Presentation transcript:

Ulcerative Colitis - before and after Hurst D.P. Jewell University of Oxford

Samuel Wilks

The London Teaching Hospitals Experience 300 cases Aetiology debated:- - bacterial (Hawkins) - tinned foods / preservatives (Phillips) - psychosomatic (Claye-Shaw) Allchin 1909

Sir Arthur Hurst

Ulcerative colitis - the Early Days Hurst (1921) described:- gradual onset limited distal disease tended to present as constipation sigmoidoscopically identical to bacillary dysentery but distinct from amoebiasis

Ulcerative colitis - the Early Days Treatment: bed rest low-fibre diet soured milk colonic irrigation - albargin (silver nucleinate) - tannic acid antidysenteric serum Hurst 1921

Anti-dysenteric antiserum for UC IV antiserum: 20, 40, 60, 80 and 100mls on consecutive days Adrenaline for anaphylaxis Relapse much less frequent if treatment continued until mucosal healing ‘Dramatic effect’ Hurst 1935 ‘Splendid results’ Crohn and Rosenak 1935

Aetiopathogenesis of UC and CD Genetic v Environment Polygenic Childhood Heritability Bacteria CD 30 - 40% Food UC 10 - 15% Drugs Appendicitis

IBD Linkage regions 2005 12 1 3 4 5 6 7 10 IBD2 IBD5 IBD3 IBD7 X IBD9 DLG5 19 IBD6 16 IBD1 NOD2 IBD8 14 IBD4 17 ‘ Crohn’s disease Linkage areas Loci studied Other linkage areas

The Gut Flora 1010-1012/G in the colon At least 500 species using 16S rRNA techniques No specific pathogen detected for UC but 5-10% with bacillary dysentery may progress to UC Prebiotics and probiotics (E. coli Nissle, VSL#3, Lactobacilli) may benefit UC and pouchitis.

The Hygiene Hypothesis Increased allergy results from decreased exposure to infections in early life (small family size, clean environment) (Strachan 1989) Some support for better living conditions in childhood associated with increased risk of IBD later in life (Gent et al) Mechanisms include altering TH1/TH2 balance, induction of T reg cells Basis of using ova of Trichuis suis as therapy to stimulate a down-regulating TH2 response.

Immune Responses to bacteria Cross-reacting antibodies between E. Coli 014 and colonic epithelium (Perlmann et al) 1992 pANCA associated with UC - 40-60% - Antigen may be a histone and may cross-react with gut flora Lamina propria cells from IBD, but not healthy subjects, proliferate to autologous gut bacterial antigens (Duchmann et al) Hypothesis:- UC represents a failure to regulate mucosal immune responses to gut antigens

Bacterial Host Interaction Adaptive immune response Presentation to T cells by dendritic cells through HLA-Class 2 and co-stimulating molecules Innate immune response Pathogen-associated molecular patterns (PAMPs) interact with pattern recognition receptors.

HLA Class 2 and UC HLA DR103:- Healthy controls <3% Severe UC 11-15% Colonic CD 15% Type 1 arthropathy 37% HLA DR2 - UC in Japan Conflicting data in Europe HLA DR4 - negative association

Pattern Recognition Receptors Toll-like receptors TLR-2 - lipoteichoic acid TLR-4 - lipopolysaccharide TLR-5 - flagellin TLR-9 - CpG DNA Caterpillar proteins (NACHT - LRRs) NOD1 - diaminopimelic acid of peptidoglycan from Gram -ve organisms NOD2 - muramyl dipeptide of PGN from Gram +ve and Gram -ve organisms

Beutler 2004

Polymorphisms in TLR2 and TLR4 TLR-2 Functional polymorphism (rs 543708) associated with colectomy in UC (McGovern et al 2006) TLR-4 - Asp 299gly 299G associated with UC and CD (Franchimont et al 2004) 299G associated with colectomy in UC No association in Scotland, Hungary - higher allele frequency in controls.

Dr Charles Elson, Challenges in IBD 2nd Edition

NOD1 and IBD NOD1 is within a region of linkage on Chr 7 Expressed in the intestine Insertion-deletion polymorphism associated with UC and CD in family-association and case-control studies McGovern et al 2005

NOD1 Family association study (UC n = 252) NDI + 32656 p<0.07 NDI/ND3 haplotype p = 0.00007 Case control (UC 306, CD358 Controls 335) IBD p = 0.017 CD p = 0.003 UC p = 0.055 McGovern et al 2005

Lessons from Animal Models Immune-manipulated mice do not develop colitis when germ-free Certain strains induce colitis more than others No single strain will induce colitis consistently in all models Host genetic background influences disease severity.

Adoptive T cell transfer model - germ-free and SPF Courtesy of Fiona Powrie

Sir Arthur Hurst

Conclusions UC probably represents an interaction between host genetic susceptibility and the commensal flora Genetic susceptibility mediated via adaptive (HLA Class 2) and the innate (NOD1, TLRs) immune response Manipulating the gut flora as a therapeutic endeavor may provide further insights into pathogenesis Factors influencing anatomical distribution of disease remain obscure - could relate to known antigenic, mucin and transport differences between R and L colon